For: | Lymperopoulos A, Wertz SL, Pollard CM, Desimine VL, Maning J, McCrink KA. Not all arrestins are created equal: Therapeutic implications of the functional diversity of the β-arrestins in the heart. World J Cardiol 2019; 11(2): 47-56 [PMID: 30820275 DOI: 10.4330/wjc.v11.i2.47] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v11/i2/47.htm |
Number | Citing Articles |
1 |
Anastasios Lymperopoulos, Jordana I. Borges. Arrestins. 2022; : 87 doi: 10.1016/B978-0-323-85756-7.00008-X
|
2 |
Reza Akbarzadeh, Antje Müller, Jens Y. Humrich, Gabriela Riemekasten. When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1213804
|
3 |
Refaat A. Eid, Mohammad Adnan Khalil, Mahmoud A. Alkhateeb, Samy M. Eleawa, Mohamed Samir Ahmed Zaki, Attalla Farag El-kott, Mubarak Al-Shraim, Fahmy El-Sayed, Muhammad Alaa Eldeen, Mashael Mohammed Bin-Meferij, Khalid M. E. Awaji, Abdullah S. Shatoor. Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial Infarction by Activating β-Arrestin-2, Protein Phosphatase 2A, and Glycogen Synthase Kinase-3 and Inhibiting β-Catenin. Cardiovascular Drugs and Therapy 2021; 35(6): 1095 doi: 10.1007/s10557-020-07006-9
|
4 |
Anastasios Lymperopoulos, Jordana I. Borges, Alexandra M. Carbone, Natalie Cora, Anastasiya Sizova. Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signaling. Pharmacological Research 2021; 174: 105943 doi: 10.1016/j.phrs.2021.105943
|
5 |
Caroline Antunes Lino, Maria Luiza Barreto-Chaves. Beta-arrestins in the context of cardiovascular diseases: Focusing on angiotensin II type 1 receptor (AT1R). Cellular Signalling 2022; 92: 110253 doi: 10.1016/j.cellsig.2022.110253
|
6 |
Xinming Wang, Abishek Iyer, A. Bruce Lyons, Heinrich Körner, Wei Wei. Emerging Roles for G-protein Coupled Receptors in Development and Activation of Macrophages. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02031
|
7 |
Xiangyan Yi, Eric Tran, Jephthah O. Odiba, Cheng Xue Qin, Rebecca H. Ritchie, Jonathan B. Baell. The formyl peptide receptors FPR1 and FPR2 as targets for inflammatory disorders: recent advances in the development of small-molecule agonists. European Journal of Medicinal Chemistry 2024; 265: 115989 doi: 10.1016/j.ejmech.2023.115989
|
8 |
Leora Boussi, William H. Frishman. β-Arrestin as a Therapeutic Target in Heart Failure. Cardiology in Review 2021; 29(5): 223 doi: 10.1097/CRD.0000000000000363
|
9 |
Krysten E. Ferraino, Natalie Cora, Celina M. Pollard, Anastasiya Sizova, Jennifer Maning, Anastasios Lymperopoulos. Adrenal angiotensin II type 1 receptor biased signaling: The case for “biased” inverse agonism for effective aldosterone suppression. Cellular Signalling 2021; 82: 109967 doi: 10.1016/j.cellsig.2021.109967
|
10 |
Anastasios Lymperopoulos, Jordana I. Borges, Malka S. Suster. Adrenal Gland. Vitamins and Hormones 2024; 124: 393 doi: 10.1016/bs.vh.2023.05.001
|
11 |
Ioannis D Kyriazis, Claudio de Lucia. Adrenergic signaling in cardiovascular aging. Current Opinion in Physiology 2024; 37: 100722 doi: 10.1016/j.cophys.2023.100722
|
12 |
Hong Zhang, Juan Chen, Min Shi, Feng Xu, Xiangcheng Zhang, Da-Wei Gong. Comparative Study of Elabela and Apelin on Apelin Receptor Activation Through β-Arrestin Recruitment. Molecular Biotechnology 2023; 65(3): 394 doi: 10.1007/s12033-022-00529-6
|
13 |
Mohammad Seyedabadi, Mehdi Gharghabi, Eugenia V. Gurevich, Vsevolod V. Gurevich. Structural basis of GPCR coupling to distinct signal transducers: implications for biased signaling. Trends in Biochemical Sciences 2022; 47(7): 570 doi: 10.1016/j.tibs.2022.03.009
|
14 |
Andrielle E. Capote, Ashley Batra, Chad M. Warren, Shamim A. K. Chowdhury, Beata M. Wolska, R. John Solaro, Paola C. Rosas. B-arrestin-2 Signaling Is Important to Preserve Cardiac Function During Aging. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.696852
|
15 |
Richard A. Bond, Martin C. Michel, Sergio Parra. Comprehensive Pharmacology. 2022; : 497 doi: 10.1016/B978-0-12-820472-6.00157-2
|
16 |
Anastasios Lymperopoulos, Natalie Cora, Jennifer Maning, Ava R. Brill, Anastasiya Sizova. Signaling and function of cardiac autonomic nervous system receptors: Insights from the GPCR signalling universe. The FEBS Journal 2021; 288(8): 2645 doi: 10.1111/febs.15771
|
17 |
Tian-Liang Ma, Yong Zhou, Chen-Yu Zhang, Zi-Ang Gao, Jia-Xi Duan. The role and mechanism of β-arrestin2 in signal transduction. Life Sciences 2021; 275: 119364 doi: 10.1016/j.lfs.2021.119364
|
18 |
Metehan Ilter, Samman Mansoor, Ozge Sensoy. Utilization of Biased G Protein-Coupled Receptor Signaling towards Development of Safer and Personalized Therapeutics. Molecules 2019; 24(11): 2052 doi: 10.3390/molecules24112052
|
19 |
Daolai Zhang, Yanfei Wang, Hui Lin, Yujing Sun, Mingwei Wang, Yingli Jia, Xiao Yu, Hui Jiang, Wenming Xu, Jin‐Peng Sun, Zhigang Xu. Function and therapeutic potential of G protein‐coupled receptors in epididymis. British Journal of Pharmacology 2020; 177(24): 5489 doi: 10.1111/bph.15252
|
20 |
Ahmed Rakib, Taslima Akter Eva, Saad Ahmed Sami, Saikat Mitra, Iqbal Hossain Nafiz, Ayan Das, Abu Montakim Tareq, Firzan Nainu, Kuldeep Dhama, Talha Bin Emran, Jesus Simal-Gandara. Beta-Arrestins in the Treatment of Heart Failure Related to Hypertension: A Comprehensive Review. Pharmaceutics 2021; 13(6): 838 doi: 10.3390/pharmaceutics13060838
|